SMAD2 and leiomyoma: In this work, we identified an anti‐leiomyoma stem cell effect of simvastatin by inhibiting the TGF‐β3/SMAD2 and Wnt4/β‐catenin signalling pathways involved in proliferation, differentiation and fibrosis (Figure 8).